14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
On July 24th, Connecticut Governor Ned Lamont signed Executive Order No. 7JJJ, which creates a rebut...
Read More >
The San Antonio, Texas City Council has approved revisions to the city’s sick and safe leave ordina...
Read More >
When you think about personal injury lawyers, is the first thing that comes to mind “what great adv...
Read More >
As healthcare providers around the country struggle to respond to patient needs during the Covid-19 ...
Read More >
Over the past few months, an increasing number of owners have decided to halt, cancel or postpone th...
Read More >
Whether you are the owner or the general contractor, dealing with mechanic’s liens filed by subcont...
Read More >